SG11201607183PA - Piperidine derivatives as orexin receptor antagonist - Google Patents
Piperidine derivatives as orexin receptor antagonistInfo
- Publication number
- SG11201607183PA SG11201607183PA SG11201607183PA SG11201607183PA SG11201607183PA SG 11201607183P A SG11201607183P A SG 11201607183PA SG 11201607183P A SG11201607183P A SG 11201607183PA SG 11201607183P A SG11201607183P A SG 11201607183PA SG 11201607183P A SG11201607183P A SG 11201607183PA
- Authority
- SG
- Singapore
- Prior art keywords
- receptor antagonist
- piperidine derivatives
- orexin receptor
- orexin
- piperidine
- Prior art date
Links
- 229940123730 Orexin receptor antagonist Drugs 0.000 title 1
- 150000003053 piperidines Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
- C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Addiction (AREA)
- Psychiatry (AREA)
- Pulmonology (AREA)
- Emergency Medicine (AREA)
- Epidemiology (AREA)
- Anesthesiology (AREA)
- Child & Adolescent Psychology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410081220 | 2014-03-06 | ||
| PCT/CN2015/073330 WO2015131773A1 (en) | 2014-03-06 | 2015-02-27 | Piperidine derivatives as orexin receptor antagonist |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201607183PA true SG11201607183PA (en) | 2016-10-28 |
Family
ID=54054589
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG10201900536TA SG10201900536TA (en) | 2014-03-06 | 2015-02-27 | Piperidine derivatives as orexin receptor antagonist |
| SG11201607183PA SG11201607183PA (en) | 2014-03-06 | 2015-02-27 | Piperidine derivatives as orexin receptor antagonist |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG10201900536TA SG10201900536TA (en) | 2014-03-06 | 2015-02-27 | Piperidine derivatives as orexin receptor antagonist |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US10100047B2 (en) |
| EP (1) | EP3115362B1 (en) |
| JP (1) | JP6262885B2 (en) |
| KR (1) | KR101920472B1 (en) |
| CN (1) | CN106414439B (en) |
| AU (1) | AU2015226679B2 (en) |
| CA (1) | CA2941663C (en) |
| CL (1) | CL2016002240A1 (en) |
| IL (1) | IL247584A0 (en) |
| MX (1) | MX2016011549A (en) |
| NZ (1) | NZ723671A (en) |
| PE (1) | PE20170184A1 (en) |
| RU (1) | RU2669701C2 (en) |
| SG (2) | SG10201900536TA (en) |
| WO (1) | WO2015131773A1 (en) |
| ZA (1) | ZA201606141B (en) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105073728A (en) | 2013-03-15 | 2015-11-18 | 全球血液疗法股份有限公司 | Compounds and uses thereof for the modulation of hemoglobin |
| EA202092627A1 (en) | 2013-11-18 | 2021-09-30 | Глобал Блад Терапьютикс, Инк. | COMPOUNDS AND THEIR APPLICATIONS FOR HEMOGLOBIN MODULATION |
| US10196383B2 (en) | 2015-07-17 | 2019-02-05 | Sunshine Lake Pharma Co., Ltd. | Substituted quinazoline compounds and preparation and uses thereof |
| DK3336088T3 (en) * | 2015-08-14 | 2021-06-28 | Shanghai Haiyan Pharmaceutical Tech Co Ltd | Crystal form of orexin receptor antagonist compound, and method of making and using the same |
| EP3380475A4 (en) | 2015-11-23 | 2019-07-03 | Sunshine Lake Pharma Co., Ltd. | OCTAHYDROPYRROLO [3, 4-c |
| JP6609060B2 (en) | 2016-02-04 | 2019-11-20 | 武田薬品工業株式会社 | Substituted piperidine compounds and uses thereof |
| US20230149402A1 (en) * | 2020-04-17 | 2023-05-18 | Shanghai Haiyan Pharmaceutical Technology Co., Ltd. | Solid pharmaceutical preparation, preparation method therefor and use thereof |
| CN112480107B (en) * | 2020-11-30 | 2022-08-16 | 上海海雁医药科技有限公司 | Substituted azabicyclooctane compounds, intermediates therefor and processes for their preparation |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1641801B9 (en) * | 2003-05-13 | 2009-02-25 | Schering Corporation | Bridged n-arylsulfonylpiperidines as gamma-secretase inhibitors |
| US20090247499A1 (en) * | 2006-08-21 | 2009-10-01 | Fletcher Joan M | Sulfonylated piperazines as cannabinoid-1 receptor modulators |
| EP2150114A4 (en) * | 2007-05-18 | 2012-01-18 | Merck Sharp & Dohme | Oxo bridged diazepan orexin receptor antagonists |
| CA2687230A1 (en) * | 2007-05-23 | 2008-12-11 | Merck & Co., Inc. | Cyclopropyl pyrrolidine orexin receptor antagonists |
| ES2379744T3 (en) * | 2007-05-23 | 2012-05-03 | Merck Sharp & Dohme Corp. | Pyridyl-piperidine antagonists of orexin receptors |
| AU2009211724B2 (en) * | 2008-02-06 | 2013-05-16 | Msd K.K. | 3-substituted sulfonyl piperazine derivative |
| JP2011512400A (en) * | 2008-02-21 | 2011-04-21 | アクテリオン ファーマシューティカルズ リミテッド | 2-Aza-bicyclo [2.2.1] heptane derivatives |
| JP2012506378A (en) * | 2008-10-21 | 2012-03-15 | メルク・シャープ・エンド・ドーム・コーポレイション | 2,3-disubstituted phenylcarboxamide orexin receptor antagonist |
| AU2009307915A1 (en) * | 2008-10-21 | 2010-04-29 | Merck Sharp & Dohme Corp. | 2,5-disubstituted piperidine orexin receptor antagonists |
| CA2739919A1 (en) * | 2008-10-21 | 2010-04-29 | Merck Sharp & Dohme Corp. | 2,4-disubstituted pyrrolidine orexin receptor antagonists |
| US8669272B2 (en) * | 2008-10-21 | 2014-03-11 | Merck Sharp & Dohme Corp. | 2,5-disubstituted piperidine orexin receptor antagonists |
| US9365564B2 (en) * | 2010-04-29 | 2016-06-14 | The University Of Edinburgh | 3,3-disubstituted-(8-aza-bicyclo[3.2.1]oct-8-yl)-[5-(1H-pyrazol-4-yl)-thiophen-3-yl]-methanones as inhibitors of 11 (β)-HSD1 |
| JP5889895B2 (en) * | 2010-07-29 | 2016-03-22 | ライジェル ファーマシューティカルズ， インコーポレイテッド | AMPK activated heterocyclic compounds and methods of use thereof |
| US20140228377A1 (en) * | 2011-07-05 | 2014-08-14 | Taisho Pharmaceutical Co., Ltd. | Methylpiperidine derivative |
| AR088352A1 (en) * | 2011-10-19 | 2014-05-28 | Merck Sharp & Dohme | ANTAGONISTS OF THE RECEIVER OF 2-PIRIDILOXI-4-NITRILE OREXINE |
| EP2752410B1 (en) * | 2011-10-25 | 2016-08-31 | Shionogi & Co., Ltd. | Heterocycle derivative having pgd2 receptor antagonist activity |
| JOP20130213B1 (en) * | 2012-07-17 | 2021-08-17 | Takeda Pharmaceuticals Co | 5-ht3 receptor antagonists |
| US9730940B2 (en) * | 2012-11-16 | 2017-08-15 | Merck Sharp & Dohme | Purine inhibitors of human phosphatidylinositol 3-kinase delta |
| TWI621618B (en) | 2013-03-13 | 2018-04-21 | 比利時商健生藥品公司 | Substituted 2-azabicycles and their use as orexin receptor modulators |
| TW201444849A (en) | 2013-03-13 | 2014-12-01 | Janssen Pharmaceutica Nv | Substituted 7-azabicycles and their use as orexin receptor modulators |
-
2015
- 2015-02-27 SG SG10201900536TA patent/SG10201900536TA/en unknown
- 2015-02-27 US US15/123,014 patent/US10100047B2/en active Active
- 2015-02-27 KR KR1020167027668A patent/KR101920472B1/en active IP Right Grant
- 2015-02-27 EP EP15758792.4A patent/EP3115362B1/en active Active
- 2015-02-27 WO PCT/CN2015/073330 patent/WO2015131773A1/en active Application Filing
- 2015-02-27 CA CA2941663A patent/CA2941663C/en active Active
- 2015-02-27 AU AU2015226679A patent/AU2015226679B2/en active Active
- 2015-02-27 NZ NZ723671A patent/NZ723671A/en unknown
- 2015-02-27 SG SG11201607183PA patent/SG11201607183PA/en unknown
- 2015-02-27 CN CN201580012396.4A patent/CN106414439B/en active Active
- 2015-02-27 JP JP2016572879A patent/JP6262885B2/en active Active
- 2015-02-27 PE PE2016001578A patent/PE20170184A1/en not_active Application Discontinuation
- 2015-02-27 RU RU2016130937A patent/RU2669701C2/en active
- 2015-02-27 MX MX2016011549A patent/MX2016011549A/en unknown
-
2016
- 2016-08-31 IL IL247584A patent/IL247584A0/en unknown
- 2016-09-05 ZA ZA2016/06141A patent/ZA201606141B/en unknown
- 2016-09-06 CL CL2016002240A patent/CL2016002240A1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| RU2669701C2 (en) | 2018-10-15 |
| CA2941663C (en) | 2020-02-18 |
| WO2015131773A1 (en) | 2015-09-11 |
| ZA201606141B (en) | 2017-05-31 |
| KR20160143668A (en) | 2016-12-14 |
| RU2016130937A (en) | 2018-04-09 |
| EP3115362A4 (en) | 2017-08-16 |
| US20170233385A1 (en) | 2017-08-17 |
| CN106414439A (en) | 2017-02-15 |
| PE20170184A1 (en) | 2017-04-07 |
| JP6262885B2 (en) | 2018-01-17 |
| CN106414439B (en) | 2017-12-08 |
| CL2016002240A1 (en) | 2017-02-17 |
| US10100047B2 (en) | 2018-10-16 |
| EP3115362B1 (en) | 2019-06-12 |
| MX2016011549A (en) | 2017-05-08 |
| CA2941663A1 (en) | 2015-09-11 |
| EP3115362A1 (en) | 2017-01-11 |
| JP2017507185A (en) | 2017-03-16 |
| NZ723671A (en) | 2017-05-26 |
| AU2015226679B2 (en) | 2017-05-25 |
| AU2015226679A1 (en) | 2016-09-15 |
| KR101920472B1 (en) | 2019-02-08 |
| SG10201900536TA (en) | 2019-02-27 |
| IL247584A0 (en) | 2016-11-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1226064A1 (en) | Azaspiro derivatives as trpm8 antagonists | |
| GB201514875D0 (en) | Receptor | |
| HK1252163A1 (en) | Receptor | |
| EP2964226A4 (en) | 2-pyridyloxy-4-ether orexin receptor antagonists | |
| EP3030234A4 (en) | Thiazole orexin receptor antagonists | |
| HK1251902A1 (en) | Bridged piperidine derivatives | |
| ZA201606141B (en) | Piperidine derivatives as orexin receptor antagonist | |
| EP3030233A4 (en) | Oxazole orexin receptor antagonists | |
| IL250888A0 (en) | Substituted piperidine compounds | |
| IL247728A0 (en) | Pyridyl piperidines | |
| DK3212637T3 (en) | DOPAMIN-D3 RECEPTOR ANTAGONIST COMPOUNDS | |
| IL251027A0 (en) | Pyrrolopyrimidine derivatives as nr2b nmda receptor antagonists | |
| ZA201704462B (en) | New benzimidazole derivatives as antihistamine agents | |
| TWM489716U (en) | Drill structure | |
| IL259726B (en) | Piperidinyl nociceptin receptor compounds | |
| HK1247916A1 (en) | Novel 5-ht2 antagonists | |
| EP3134092A4 (en) | Pharmaceutical salts of an orexin receptor antagonist | |
| HK1231414A1 (en) | 5-ht4 receptor agonist for gastroparesis 5-ht4 | |
| EP3388423A4 (en) | Nk1 receptor antagonist | |
| PT3233825T (en) | Diarylmethylidene piperidine derivatives and their use as delta opioid receptor agonists | |
| EP3162366A4 (en) | Sweetness receptor antagonist | |
| GB201419433D0 (en) | Dopamine D3 receptor antagonist compounds | |
| GB201419430D0 (en) | Dopamine D3 receptor antagonist compounds | |
| TWM489894U (en) | Improved structure for tile | |
| GB201413003D0 (en) | Self-correcting horizontal drilling fishbone well |